Melanoma, Secondary cancers, Skin cancer
Results
Phase 2
This trial was for people with advanced melanoma and a change in a gene called BRAF. It compared taking tablets every day to having regular breaks in treatment.
The trial was open for people to join between 2017 and 2020. The team finished analysing the results in 2023
Recruitment start: 20 December 2017
Recruitment end: 31 March 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Pippa Corrie
Cambridge University Hospitals NHS Foundation Trust
NIHR Research for Patient Benefit (RfPB) Programme
Cancer Research UK
University of Oxford
Oxford University NHS Foundation Trust
Last reviewed: 14 June 2023
CRUK internal database number: 15242
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
